Virtu KCG Holdings’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Virtu KCG Holdings’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-106,772	Closed	-$128K	–	4172
2015 Q2	$128K	Buy	106,772 +44,125	+70%	+$56.2K	﹤0.01%	2828
2015 Q1	$66K	Buy	62,647 +7,443	+13%	+$7.7K	﹤0.01%	2761
2014 Q4	$60K	Buy	55,204 +14,501	+36%	+$15.2K	﹤0.01%	3382
2014 Q3	$44K	Buy	40,703 +3,647	+10%	+$4.5K	﹤0.01%	3374
2014 Q2	$39K	Buy	37,056 +19,635	+113%	+$18.7K	﹤0.01%	3463
2014 Q1	$18K	Sell	17,421 -19,022	-52%	-$19.6K	﹤0.01%	3441
2013 Q4	$42K	Buy	36,443 +14,067	+63%	+$21.7K	﹤0.01%	3635
2013 Q3	$38K	Buy	+22,376	New	+$41.4K	﹤0.01%	3544

Other funds holding ENZN

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Virtu KCG Holdings's ENZN Position: Q3 2015 in Review

Virtu KCG Holdings sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2015, closing a stake of 106,772 shares — an estimated $128K sold.

Virtu KCG Holdings first reported a position in ENZN in Q3 2013 and held it in 8 quarters. The position peaked at $128K in Q2 2015. 53 funds tracked by Wall St. Rank hold ENZN as of Q3 2015.

Virtu KCG Holdings reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2015 after selling out during the quarter.
Virtu KCG Holdings sold 106,772 ENZON PHARMACEUTICALS INC shares in Q3 2015, an estimated $128K.
Virtu KCG Holdings first reported a position in ENZON PHARMACEUTICALS INC in Q3 2013 and held it in 8 quarters.
Virtu KCG Holdings's ENZON PHARMACEUTICALS INC position peaked at $128K in Q2 2015.
53 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2015.

Based on Virtu KCG Holdings's 13F filing for Q3 2015, filed 13 Nov 2015.